BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25003957)

  • 21. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells.
    Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M
    Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell Type-Dependent Nonspecific Fibroblast Growth Factor Signaling in Apert Syndrome.
    Yeh E; Atique R; Fanganiello RD; Sunaga DY; Ishiy FA; Passos-Bueno MR
    Stem Cells Dev; 2016 Aug; 25(16):1249-60. PubMed ID: 27339175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIN1 Attenuation Improves Midface Hypoplasia in a Mouse Model of Apert Syndrome.
    Kim B; Shin H; Kim W; Kim H; Cho Y; Yoon H; Baek J; Woo K; Lee Y; Ryoo H
    J Dent Res; 2020 Feb; 99(2):223-232. PubMed ID: 31869252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIN1 is a new therapeutic target of craniosynostosis.
    Shin HR; Bae HS; Kim BS; Yoon HI; Cho YD; Kim WJ; Choi KY; Lee YS; Woo KM; Baek JH; Ryoo HM
    Hum Mol Genet; 2018 Nov; 27(22):3827-3839. PubMed ID: 30007339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse models of Apert syndrome.
    Holmes G
    Childs Nerv Syst; 2012 Sep; 28(9):1505-10. PubMed ID: 22872267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models.
    Martínez-Abadías N; Heuzé Y; Wang Y; Jabs EW; Aldridge K; Richtsmeier JT
    PLoS One; 2011; 6(10):e26425. PubMed ID: 22053191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The primary site of the acrocephalic feature in Apert Syndrome is a dwarf cranial base with accelerated chondrocytic differentiation due to aberrant activation of the FGFR2 signaling.
    Nagata M; Nuckolls GH; Wang X; Shum L; Seki Y; Kawase T; Takahashi K; Nonaka K; Takahashi I; Noman AA; Suzuki K; Slavkin HC
    Bone; 2011 Apr; 48(4):847-56. PubMed ID: 21129456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Fgfr2(S252W/+) mutation in mice retards mandible formation and reduces bone mass as in human Apert syndrome.
    Zhou X; Pu D; Liu R; Li X; Wen X; Zhang L; Chen L; Deng M; Liu L
    Am J Med Genet A; 2013 May; 161A(5):983-92. PubMed ID: 23495007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation.
    Chen P; Zhang L; Weng T; Zhang S; Sun S; Chang M; Li Y; Zhang B; Zhang L
    PLoS One; 2014; 9(1):e87311. PubMed ID: 24489893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
    Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
    J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
    Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
    Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome.
    Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X
    Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.
    Shen K; Krakora SM; Cunningham M; Singh M; Wang X; Hu FZ; Post JC; Ehrlich GD
    Orthod Craniofac Res; 2009 Aug; 12(3):254-62. PubMed ID: 19627528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maldevelopment of the submandibular gland in a mouse model of apert syndrome.
    Yamaji K; Morita J; Watanabe T; Gunjigake K; Nakatomi M; Shiga M; Ono K; Moriyama K; Kawamoto T
    Dev Dyn; 2018 Nov; 247(11):1175-1185. PubMed ID: 30251381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain phenotypes in two FGFR2 mouse models for Apert syndrome.
    Aldridge K; Hill CA; Austin JR; Percival C; Martinez-Abadias N; Neuberger T; Wang Y; Jabs EW; Richtsmeier JT
    Dev Dyn; 2010 Mar; 239(3):987-97. PubMed ID: 20077479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
    Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT
    Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midface and upper airway dysgenesis in FGFR2-related craniosynostosis involves multiple tissue-specific and cell cycle effects.
    Holmes G; O'Rourke C; Motch Perrine SM; Lu N; van Bakel H; Richtsmeier JT; Jabs EW
    Development; 2018 Oct; 145(19):. PubMed ID: 30228104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.
    Neben CL; Idoni B; Salva JE; Tuzon CT; Rice JC; Krakow D; Merrill AE
    Hum Mol Genet; 2014 Nov; 23(21):5659-71. PubMed ID: 24908667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.